01
The Myth of the Complete Patient
This article argues that even as multiomic and AI driven diagnostics generate unprecedented volumes of data, the belief that this will produce a complete understanding of the patient is misguided because interpretability, meaning, and clinical context still lag far behind what the data imply.
02
The $100B Mirage: Rethinking Market Sizing in Biopharma
This essay explains how common TAM, SAM, and SOM models in biopharma often create a false sense of precision because market boundaries are blurry, assumptions compound, and categories overlap, and it makes the case for a probabilistic and scenario based approach to market modeling.
03
Climate Defense Project and Fossil Free Stanford file legal complaint against Stanford
This piece reports on student environmental groups filing a legal complaint that challenged Stanford’s fossil fuel investment strategy and argues that the university’s financial practices must align with its public commitments to sustainability and transparency.
04
Comparing Stanford’s COVID 19 response with peer institutions
An in depth comparison of Stanford’s pandemic policies with those of peer universities that evaluates testing capacity, quarantine logistics, communication clarity, and tradeoffs between public health measures and student experience.
05
Stanford endowment 101: Visualizing performance over time, against peers
This article breaks down the most recent endowment return data for Stanford, compares performance with peer institutions, and explains what the numbers reveal about long-term financial health and funding stability.
06
Stanford Tech History Project
This contribution to the Stanford Tech History Project helped document how the University’s ties with technology, entrepreneurship, and Silicon Valley evolved over the 2010s by collecting data, conducting interviews, and producing analysis that highlighted growth, equity issues, and institutional dynamics within the Stanford tech ecosystem.